CURE Pharmaceutical to Present on the Increased Bioavailability for Cannabinoids Due to New Delivery Technologies at O’Cannabiz Conference
June 05, 2018 08:57 ET
|
CURE Pharmaceutical
LOS ANGELES, June 05, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced that CEO Rob Davidson will be presenting at the...
CURE Pharmaceutical Secures Two Patents for the Extraction and Purification of Bioactive Cannabinoid Molecules
April 04, 2018 08:57 ET
|
CURE Pharmaceutical
LOS ANGELES, April 04, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the acquisition of two patents that ensure CURE...
CURE Pharmaceutical Reports Strong Progress and Sets Growth Roadmap for Remainder of Year
April 03, 2018 08:57 ET
|
CURE Pharmaceutical
OXNARD, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery company, today reported the company’s Q1 2018 accomplishments. The company strengthened...
CURE Pharmaceutical Adds Healthcare Luminary To Advisory Board, Secures $1 Million Investment as a Bridge to Uplisting
February 21, 2018 06:00 ET
|
CURE Pharmaceutical
OXNARD, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced Gene Salkind, M.D. joined the company’s...
Cure Pharmaceutical Enters Into Product Development Agreement with Therapix Biosciences To Develop Cannabinoid-Based Product For Sleep Disorders
November 07, 2017 09:00 ET
|
CURE Pharmaceutical; Therapix Biosciences Ltd.
OXNARD, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Cure Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology announced today that it has entered into a product...
CURE Pharmaceutical Announces Entrance Into Booming Pharmaceutical Cannabis Industry
May 10, 2017 09:00 ET
|
CURE Pharmaceutical
Oxnard, Calif., May 10, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology company researching and developing drug and...
CURE Pharmaceutical Strengthens Senior Leadership Team with Appointment of Industry Veteran Richard Serbin as Head of Global Corporate Development
May 09, 2017 09:00 ET
|
CURE Pharmaceutical
OXNARD, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology company researching cannabinoid molecules for various...
CURE Pharmaceutical Adds Industry Veteran, Anti-Aging Specialist and Medicinal Cannabis Supporter, Alan Einstein, to Its Board of Directors
May 03, 2017 09:00 ET
|
CURE Pharmaceutical
OXNARD, Calif., May 03, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology company researching cannabinoid molecules for various...